The Claim
In older adults with low-grade chronic inflammation, plasma concentrations of DHA-derived lipid mediators 14-HDHA and 4-HDHA are inversely associated with serum monocyte chemoattractant protein-1 (MCP-1), and these intermediates contribute to the regulation of monocyte recruitment in inflammation.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In older adults with low-grade chronic inflammation, higher levels of specific DHA-derived molecules in the blood are linked to lower levels of MCP-1, a protein involved in attracting monocytes to sites of inflammation.
See the scientific wording
In older adults with low-grade chronic inflammation, plasma concentrations of DHA-derived lipid mediators 14-HDHA and 4-HDHA are inversely associated with serum monocyte chemoattractant protein-1 (MCP-1), suggesting these intermediates may contribute to the regulation of monocyte recruitment in inflammation.
When DHA, a fat from fish, enters immune cells, it gets turned into specific molecules called 14-HDHA and 4-HDHA. These molecules bind to receptors on monocytes, which blocks a key switch called NF-κB from turning on genes that make MCP-1. With less MCP-1 being made, fewer monocytes are pulled into inflamed tissues, reducing chronic inflammation.
What the research says
1 studyIn older adults with long-term inflammation, scientists found that higher levels of certain natural compounds from fish oil (14-HDHA and 4-HDHA) were linked to lower levels of a protein (MCP-1) that pulls immune cells to inflamed areas — suggesting these compounds may help calm excessive immune activity.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.